Venture capital firm Norwest Venture Partners (NVP), which invests on behalf of bank Wells Fargo, has reinvested in its first investment in India by backing Perfint Healthcare, a firm set up in 2005 making medical equipment to detect cancer. NVP invested $11m in Perfint’s series D round. In July 2010, NVP had led the $7.2m series B round in Perfint, which included participation from previous investors, VC firm Accel Partners (India) and IDG Ventures India, a $150m country-focused corporate venturing fund of US-based technology publisher International Data Group. IDG had previously invested $3m in a $3.5m series A round for Perfint, with the remainder coming from early stage India-based VC Erasmic Venture Fund, which merged with Accel in 2008 to establish the US firm’s presence in the country. Separately, Norwest this year has invested R22crores ($4m) in NueClear Healthcare in India, an affiliate of NVP-backed Thyrocare Technologies as it shares a founder, A Velumani. This year in the US, NVP invested $35m in US-based services business Pics Auditing, led a $33m B round for Health Catalyst, supported the ToPo Athletics start-up and a $50m round for FireEye.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?